Cargando…

Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity

Inhibitors that block the programmed cell death-1 (PD-1) pathway can potentiate endogenous antitumor immunity and have markedly improved cancer survival rates across a broad range of indications. However, these treatments work for only a minority of patients. The efficacy of anti-PD-1 inhibitors may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Shanling, Sckisel, Gail, Sahoo, Anupama, Lalani, Almin, Otter, Doug Den, Pearson, Josh, DeVoss, Jason, Cheng, Jay, Casey, Stephanie C., Case, Ryan, Yang, Melissa, Low, Ray, Daris, Mark, Fan, Bin, Agrawal, Neeraj J., Ali, Khaled
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225340/ https://www.ncbi.nlm.nih.gov/pubmed/32457754 http://dx.doi.org/10.3389/fimmu.2020.00832

Ejemplares similares

MuteinDB: the mutein database linking substrates, products and enzymatic reactions directly with genetic variants of enzymes
por: Braun, Andreas, et al.
Publicado: (2012)

Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo
por: Ma, Shining, et al.
Publicado: (2023)

Utilizing BMP-2 muteins for treatment of multiple myeloma
por: Seher, Axel, et al.
Publicado: (2017)

Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein
por: Lu, Daniel R, et al.
Publicado: (2020)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Mechanical Disruption of Tumors by Iron Particles and Magnetic Field Application Results in Increased Anti-Tumor Immune Responses
por: Bouchlaka, Myriam N., et al.
Publicado: (2012)

A novel Mutein of TNFα Containing the Arg-Gly-Asp Sequence Shows Reduced Toxicity in Intestine
por: Shikama, H., et al.
Publicado: (1994)

A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics
por: Lee, Saehyung, et al.
Publicado: (2019)

Evaluation of Adverse Effects of Mutein Forms of Recombinant Human Interferon Alpha-2b in Female Swiss Webster Mice
por: Rachmawati, H., et al.
Publicado: (2013)

A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
por: Peterson, Laurence B., et al.
Publicado: (2018)

A simple approach for preparation of affinity matrices: Simultaneous purification and reversible immobilization of a streptavidin mutein to agarose matrix
por: Wu, Sau-Ching, et al.
Publicado: (2017)

Receptor-selective interleukin-4 mutein attenuates laser-induced choroidal neovascularization through the regulation of macrophage polarization in mice
por: Gao, Limo, et al.
Publicado: (2021)

The antitumor effect induced by an IL-2 ‘no-alpha’ mutein depends on changes in the CD8(+) T lymphocyte/Treg cell balance
por: Carmenate, Tania, et al.
Publicado: (2022)

Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells
por: Sckisel, Gail D., et al.
Publicado: (2012)

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388
por: Góra-Tybor, J., et al.
Publicado: (1995)

Development of a Tetrameric Streptavidin Mutein with Reversible Biotin Binding Capability: Engineering a Mobile Loop as an Exit Door for Biotin
por: O'Sullivan, Valerie J., et al.
Publicado: (2012)

Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
por: Ghelani, Aazam, et al.
Publicado: (2020)

Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein
por: Munoz Pinto, Mario F, et al.
Publicado: (2021)

Fuse your mitochondria, lose appetite: an anorexic, anti‐obesity sphingolipid
por: Muley, Carolin, et al.
Publicado: (2021)

Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein
por: de Picciotto, Seymour, et al.
Publicado: (2022)

The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines
por: Fiedor, Elżbieta, et al.
Publicado: (2016)

A novel human IL-2 mutein with minimal systemic toxicity exerts greater antitumor efficacy than wild-type IL-2
por: Chen, Xi, et al.
Publicado: (2018)

Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma
por: Fiedor, E., et al.
Publicado: (2017)

A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy
por: Chen, Alex C., et al.
Publicado: (2020)

Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells
por: Inoue, Masaki, et al.
Publicado: (2023)

Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions
por: Roy, Sumedha, et al.
Publicado: (2023)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-α and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice
por: Warzocha, K., et al.
Publicado: (1994)

Diphtheria recombinant vaccine; comprises Corynebacterium diphtheriae toxin-A fragment mutein, Gly158 DT-A, which is enzymatically inactive; DNA sequence
Publicado: (1991)

The Anti-Cancer Potency and Mechanism of a Novel Tumor-Activated Fused Toxin, DLM
por: Sun, Dejun, et al.
Publicado: (2015)

Anti-Herpetic, Anti-Dengue and Antineoplastic Activities of Simple and Heterocycle-Fused Derivatives of Terpenyl-1,4-Naphthoquinone and 1,4-Anthraquinone †
por: Roa-Linares, Vicky C., et al.
Publicado: (2019)

Regulation of Physical Microglia–Neuron Interactions by Fractalkine Signaling after Status Epilepticus
por: Eyo, Ukpong B., et al.
Publicado: (2017)

Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity
por: Kim, Jennie C., et al.
Publicado: (2022)

Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing
por: Lee, Chan Gyu, et al.
Publicado: (2021)

1-calcium phosphate-uracil, a synthesized pyrimidine derivative agent, has anti-proliferative, pro-apoptotic and anti-invasion effects on multiple tumor cell lines
por: PENG, JING, et al.
Publicado: (2014)

To FUSE(x) or not to FUSE(x) ...
por: Peters, Andreas Joachim
Publicado: (2020)

Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help
por: Monjazeb, Arta M., et al.
Publicado: (2014)

Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity
por: Baccon-Sollier, Paul Le, et al.
Publicado: (2020)

1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation
por: Ashok, Dongamanti, et al.
Publicado: (2018)

The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion
por: Zhu, Sining, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n2cf31gmakufbnvfa0sp8bnfj2